QS Investors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

QS Investors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-19,997	Closed	-$1.08M	–	2006
2017 Q4	$1.08M	Sell	19,997 -767	-4%	-$42K	0.01%	785
2017 Q3	$1.19M	Sell	20,764 -2,122	-9%	-$124K	0.01%	768
2017 Q2	$1.38M	Hold	22,886	–	–	0.01%	689
2017 Q1	$1.25M	Buy	+22,886	New	+$1.13M	0.01%	735

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

QS Investors's BIVV Position: Q1 2018 in Review

QS Investors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 19,997 shares — an estimated $1.08M sold.

QS Investors first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.38M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

QS Investors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
QS Investors sold 19,997 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.08M.
QS Investors first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
QS Investors's Bioverativ Inc. Common Stock position peaked at $1.38M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on QS Investors's 13F filing for Q1 2018, filed 15 May 2018.